title: Molecular targets in the National Cancer Institute drug screen.
authors.affiliation: Medicine Branch, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: S E
authors.initials: SE
authors.lastname: Bates
authors.forename: A T
authors.initials: AT
authors.lastname: Fojo
authors.forename: J N
authors.initials: JN
authors.lastname: Weinstein
authors.forename: T G
authors.initials: TG
authors.lastname: Myers
authors.forename: M
authors.initials: M
authors.lastname: Alvarez
authors.forename: K D
authors.initials: KD
authors.lastname: Pauli
authors.forename: B A
authors.initials: BA
authors.lastname: Chabner
mesh_terms: D000970:Antineoplastic Agents; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured / Q000187:drug effects; D016000:Cluster Analysis; D018432:Drug Resistance, Multiple; D004354:Drug Screening Assays, Antitumor; D006131:Growth Inhibitors; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States
chemical_list: D000970:Antineoplastic Agents; D006131:Growth Inhibitors